Pharvaris N.V.
PHVS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,000,044 | $974,242 | $352,867 | $384,849 |
| - Cash | $280,728 | $391,232 | $161,837 | $209,353 |
| + Debt | $861 | $239 | $437 | $250 |
| Enterprise Value | $720,177 | $583,249 | $191,466 | $175,746 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$145,593 | -$96,656 | -$86,562 | -$54,061 |
| % Margin | – | – | – | – |
| Net Income | -$134,221 | -$100,875 | -$76,333 | -$42,731 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.48 | -2.63 | -2.27 | -1.41 |
| % Growth | 5.7% | -15.9% | -61% | – |
| Operating Cash Flow | -$120,130 | -$93,049 | -$67,163 | -$44,600 |
| Capital Expenditures | -$538 | -$90 | -$124 | -$130 |
| Free Cash Flow | -$120,668 | -$93,139 | -$67,287 | -$44,730 |